Legionella pneumophila LPS to evaluate urinary antigen tests

Area of Science:

• Clinical microbiology
• Diagnostic test evaluation
• Infectious disease diagnostics

Background:

• Legionnaires' disease is a severe pneumonia caused by Legionella pneumophila.
• Urinary antigen tests are crucial for rapid Legionnaires' disease diagnosis.
• Performance variations in these tests necessitate thorough evaluation.

Purpose of the Study:

• To compare the diagnostic performance of three urinary antigen tests for Legionella pneumophila.
• To assess the impact of Legionella pneumophila serogroup and strain type on test sensitivity.

Main Methods:

• Purified Legionella pneumophila (Lp) lipopolysaccharide (LPS) was used to determine the limits of detection (LOD) for three urinary antigen tests.
• Tests evaluated included Sofia®FIA, Binax®EIA, and BinaxNOW®.
• LPS from Lp serogroup 1 (Pontiac and non-Pontiac strains) and other Lp serogroups were utilized.

Main Results:

• For Lp serogroup 1, Sofia®FIA and Binax®EIA demonstrated similar limits of detection, while BinaxNOW® had a lower limit of detection.
• All tested urinary antigen tests showed a higher limit of detection for LPS from non-Pontiac strains compared to Pontiac strains.
• The limits of detection were variable across different Lp serogroups.

Conclusions:

• Urinary antigen test performance for Legionella pneumophila varies significantly based on serogroup and strain type.
• These findings highlight the need for improved diagnostic accuracy and broader serogroup coverage in Legionnaires' disease testing.
• Further research is warranted to optimize Legionella urinary antigen detection methods.